Ilpio (Indapamide, Telmisartan)

Indapamide reduces sodium reabsorption in the distal tubule, promoting diuresis and modest vasodilation. Telmisartan blocks the angiotensin II type‑1 receptor, preventing vasoconstriction and aldosterone‑mediated fluid retention. Together they decrease blood volume and systemic vascular resistance, resulting in a sustained antihypertensive effect.

The dosage of Ilpio is individualized by the prescribing clinician based on the patient’s blood pressure, renal function, and response to therapy. The prescriber determines the appropriate strength, frequency, and any necessary titration, following local prescribing guidelines.

Safety of Ilpio in pregnancy or lactation has not been fully established. Clinicians should weigh potential benefits against risks and consider alternative therapies. Women who are pregnant, planning pregnancy, or breastfeeding should discuss treatment options with their healthcare provider.

To order Ilpio, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ilpio offers a dual mechanism by combining a thiazide‑like diuretic with an angiotensin II receptor blocker, which can provide more consistent blood‑pressure control than monotherapy. Compared with single‑agent ACE inhibitors or calcium‑channel blockers, the combination may reduce the need for additional drugs but requires monitoring for electrolyte changes.

Ilpio should be stored at ambient temperature below 25 °C (77 °F). Keep the tablets in the original packaging, protect them from moisture, heat, and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Ilpio is taken orally, usually once daily, with or without food, as directed by the prescribing physician. Swallow the tablet whole with a glass of water and do not crush or chew it unless specifically instructed.

Serious risks include severe electrolyte disturbances such as hyponatremia or hyperkalaemia, acute kidney injury, and angio‑edema that can affect the airway. Patients should seek immediate medical attention if they experience swelling of the face, lips, tongue, or difficulty breathing.

Ilpio is contraindicated in patients with known hypersensitivity to indapamide, telmisartan, or any component of the formulation. It should also be avoided in individuals with severe renal impairment, hyperkalaemia, or those taking potassium‑sparing diuretics without close monitoring.